ConductScience.org, home

Paper34711990

Direct targeting of amplified gene loci for proapoptotic anticancer therapy.

Kaushik Tiwari M and 11 others. Nat Biotechnol, 2022. Cited by 25 papers, by iCite.

Cite this record

ConductScience Library. Direct targeting of amplified gene loci for proapoptotic anticancer therapy. Papers, record 34711990. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34711990

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Direct targeting of amplified gene loci for proapoptotic anticancer therapy.
PubMed
Journal
Nat Biotechnol
PubMed
Year
2022
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
25
iCite
Relative citation ratio, by iCite
1.58
iCite
Revised in PubMed
2026-11-02
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kaushik Tiwari MMeetu
2Colon-Rios DADaniel Ahttps://orcid.org/0000-0003-4672-3493
3Tumu HCRHemanta C Rao
4Liu YYanfeng
5Quijano EElias
6Krysztofiak AAdamhttps://orcid.org/0000-0001-7813-7806
7Chan CCynthia
8Song EErichttps://orcid.org/0000-0001-5448-5865
9Braddock DTDemetrios T
10Suh HWHee-Won
11Saltzman WMW Markhttps://orcid.org/0000-0002-2163-549X
12Rogers FAFaye Ahttps://orcid.org/0000-0002-1454-9892

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Gene AmplificationMajor topic
DNA Damage
Female
Genomics
Humans
Oligonucleotides

Source PubMed

Download CSV of topics

Grants6

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 GM126211NIGMS NIH HHSUnited StatesR01GM126211PubMed and NIHNIH RePORTER
R21 CA185192NCI NIH HHSUnited StatesR21CA185192PubMed and NIHNIH RePORTER
T32 GM136651NIGMS NIH HHSUnited StatesT32GM136651PubMedNIH RePORTER
R01CA149128NIHNIH RePORTER
T32GM007205NIHNIH RePORTER
T32GM007223NIHNIH RePORTER

Download CSV of grants

References2

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17585609ERBB-2 (HER2/neu) gene copy number, p185HER-2 overexpression, and intratumor heterogeneity in human breast cancer.Cancer Res1995https://conductscience.org/library/papers/7585609PubMed
211406568
Down-regulation of the erbB-2 receptor by trastuzumab (herceptin) enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2.
Cancer Res2001https://conductscience.org/library/papers/11406568PubMed

Download CSV of references

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.

PMIDTitleJournalYearIn PapersSource
42492518Self-sufficient killing of malignant tumors by an engineered cancer-selective gene circuit.Cell Rep Med2026https://conductscience.org/library/papers/42492518PubMed
42385711Targeted DNA triplex-forming oligonucleotide liposome for pulmonary fibrosis gene therapy.Cell Rep Med2026https://conductscience.org/library/papers/42385711PubMed
41127334Cell-penetrating antibody enhances nuclear delivery of triplex-forming oligonucleotides targeting HER2-positive cancers.Mol Ther Nucleic Acids2025https://conductscience.org/library/papers/41127334PubMed
40506395Efficacy of DNA Intercalator-Conjugated Triplex-Forming Oligonucleotide as Anticancer Agent.ChemMedChem2025https://conductscience.org/library/papers/40506395PubMed
40319546Weaponizing CRISPR/Cas9 for selective elimination of cells with an aberrant genome.DNA Repair (Amst)2025https://conductscience.org/library/papers/40319546PubMed
39843926Development and functional evaluation of a psoralen-conjugated nucleoside mimic for triplex-forming oligonucleotides.Commun Chem2025https://conductscience.org/library/papers/39843926PubMed
39223307Chemoproteomic profiling unveils binding and functional diversity of endogenous proteins that interact with endogenous triplex DNA.Nat Chem2024https://conductscience.org/library/papers/39223307PubMed
38661214TTSBBC: triplex target site biomarkers and barcodes in cancer.Nucleic Acids Res2024https://conductscience.org/library/papers/38661214PubMed
38019857Adaptive DNA amplification of synthetic gene circuit opens a way to overcome cancer chemoresistance.Proc Natl Acad Sci U S A2023https://conductscience.org/library/papers/38019857PubMed
37896275Recent Advancements in Development and Therapeutic Applications of Genome-Targeting Triplex-Forming Oligonucleotides and Peptide Nucleic Acids.Pharmaceutics2023https://conductscience.org/library/papers/37896275PubMed
37850170Label-Free Virtual HER2 Immunohistochemical Staining of Breast Tissue using Deep Learning.BME Front2022https://conductscience.org/library/papers/37850170PubMed
37630183Surface Characteristics Affect the Properties of PLGA Nanoparticles as Photothermal Agents.Micromachines (Basel)2023https://conductscience.org/library/papers/37630183PubMed
37468837Nanoparticle delivery of TFOs is a novel targeted therapy for HER2 amplified breast cancer.BMC Cancer2023https://conductscience.org/library/papers/37468837PubMed
37108234In Vitro and In Vivo Effects of the Combination of Polypurine Reverse Hoogsteen Hairpins against HER-2 and Trastuzumab in Breast Cancer Cells.Int J Mol Sci2023https://conductscience.org/library/papers/37108234PubMed
36817975Ferroptosis: challenges and opportunities for nanomaterials in cancer therapy.Regen Biomater2023https://conductscience.org/library/papers/36817975PubMed
36618947Triplex-forming oligonucleotides as an anti-gene technique for cancer therapy.Front Pharmacol2022https://conductscience.org/library/papers/36618947PubMed
35359341KIF26B in the Prognosis and Immune Biomarking of Various Cancers: A Pan-Cancer Study.J Oncol2022https://conductscience.org/library/papers/35359341PubMed
35355264Unravelling the tumour genome: The evolutionary and clinical impacts of structural variants in tumourigenesis.J Pathol2022https://conductscience.org/library/papers/35355264PubMed
34837080Amplifying targeting.Nat Rev Cancer2022https://conductscience.org/library/papers/34837080PubMed

Download CSV of cited by

Genes18

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ANXA5308PubTator's text mininghttps://conductscience.org/library/genes/308NCBI Gene
ATM472PubTator's text mininghttps://conductscience.org/library/genes/472NCBI Gene
BRCA2675PubTator's text mininghttps://conductscience.org/library/genes/675NCBI Gene
CASP3836PubTator's text mininghttps://conductscience.org/library/genes/836NCBI Gene
CHEK11111PubTator's text mininghttps://conductscience.org/library/genes/1111NCBI Gene
CHEK211200PubTator's text mininghttps://conductscience.org/library/genes/11200NCBI Gene
COL11A21302PubTator's text mininghttps://conductscience.org/library/genes/1302NCBI Gene
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene
ERBB32065PubTator's text mininghttps://conductscience.org/library/genes/2065NCBI Gene
ERBB42066PubTator's text mininghttps://conductscience.org/library/genes/2066NCBI Gene
ERCC22068PubTator's text mininghttps://conductscience.org/library/genes/2068NCBI Gene
GAPDH2597PubTator's text mininghttps://conductscience.org/library/genes/2597NCBI Gene
H2AX3014PubTator's text mininghttps://conductscience.org/library/genes/3014NCBI Gene
POTEF728378PubTator's text mininghttps://conductscience.org/library/genes/728378NCBI Gene
TP537157PubTator's text mininghttps://conductscience.org/library/genes/7157NCBI Gene
TP53BP17158PubTator's text mininghttps://conductscience.org/library/genes/7158NCBI Gene
TXK7294PubTator's text mininghttps://conductscience.org/library/genes/7294NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34711990

GET https://conductscience.org/api/papers/v1/34711990/authors